PeptiDream Inc. provided consolidated earnings guidance for the year ending December 31, 2023. For the year, the company expects revenue to be JPY 30,000 million, Operating profit to be JPY 6,300 million, Profit attributable to owners of parent to be JPY 2,700 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,962 JPY | -0.18% | -1.65% | +31.99% |
May. 07 | Jefferies Adjusts PeptiDream’s Price Target to 1,900 Yen From 1,400 Yen, Keeps at Hold | MT |
Apr. 30 | Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.99% | 1.63B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- 4587 Stock
- News PeptiDream Inc.
- PeptiDream Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023